IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2025
Total Assets: $9.7M
Liabilities Breakdown FY2025
Total Liabilities: $2.3M
Asset Breakdown
Total Assets: $9.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $900.0K | 9.3% |
| Accounts Receivable | $12.0K | 0.1% |
| Inventory | $640.0K | 6.6% |
| Property, Plant & Equipment | $2.1M | 22.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $5.1M | 52.5% |
| Other Assets | $918.0K | 9.5% |
Liabilities Breakdown
Total Liabilities: $2.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.0M | 44.3% |
| Long-Term Debt | $131.0K | 5.7% |
| Other Liabilities | $1.1M | 50.0% |